• Estrogen’s Impact on Cancer Reveals New Treatment Options

    Oct 17 | Clinical Research News | A groundbreaking new approach for treating triple-negative breast cancer is moving forward, thanks to discoveries from Dr. Donald McDonnell’s lab at Duke University. Traditionally, hormone therapies have only been considered effective for estrogen receptor-positive cancers, but McDonnell’s research suggests that estrogen modulation could also impact TNBC. More

  • Psst! Need a Simple and Reliable Eye Tracker for Your Brain Studies?

    Oct 15 | Clinical Research News | A mechanical engineer at the University of Houston is seeking physician collaborators with a research need for a small but sensitive wearable eye-tracking system to provide continuous data on human brain activity. The need was suggested by a survey of the literature, which found that a shortage of data coming from devices used in supervised clinical settings was resulting in inconclusive correlations study after study. More

  • Catching Up With Jill Pellegrino, Now Leading AutoCruitment

    Oct 10 | Clinical Research News | For as long as most people can remember, patient enrollment into clinical trials has been abysmal—so much so that 80% of studies don’t finish on time and 55% end due to low accrual rates. The underlying issue is overreliance on study sites to find participants on their own. More

  • CluePoints Launches Medical & Safety Review (MSR) Software

    Oct 09 | Clinical Research News | CluePoints has launched its Medical & Safety Review (MSR) tool that aims to simplify and streamline the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the data history. More

  • Curing Data Collection Woes Could Take a Village

    Oct 08 | Clinical Research News | The average clinical trial generates three times as much data as it did a decade ago, and yet there are no standards in place for how that information should be collected. That’s a big problem for many reasons, not the least of which is that drug developers may be missing key insights about the way interventions are working in individuals and across populations. More

  • Study Aims to Resolve Variants of Uncertain Significance

    Oct 03 | Clinical Research News | A pioneering study led by Dr. Lachlan Jolly at the University of Adelaide’s Neurobiology Research Group is transforming genetic diagnostics by resolving variants of uncertain significance (VUS) using skin samples. Many patients with VUS lack a definitive diagnosis because RNA from disease-causing genes often can't be extracted from accessible tissues like blood or skin. More

  • Scope of Things: Trial Planning Skews Conclusions, AI Diversity Help, News of the Month

    Oct 02 | Clinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz covers everything you need to know about a pending launch of a large treatment trial for Graves’ disease, a recruitment campaign for a diagnostic tampon, Walgreens and BARDA’s new partnership, how eligibility criteria has been excluding people of African or Middle Eastern descent from cancer studies, and more. More

  • Follow the Money: GPCR Targets, Upacicalcet, AAV-Delivered Cancer Immunotherapy, More

    Sep 26 | Clinical Research News | Superluminal Medicines is focusing on supporting the progression of their lead program into clinical development and increase the number of small molecule drug discovery programs focused on high-value G protein-coupled receptor (GPCR) targets; Pathalys Pharma wraps up upacicalcet clinical trials; Vironexis anticipates initiating patient enrollment of a Phase 1/2 trial of VNX-101 in the fourth quarter of 2024, which will mark the first-ever clinical trial of an AAV-delivered cancer immunotherapy; and more. More

  • AstraZeneca, Moffitt Cancer Center Partner, Firefly Neuroscience Advances AI Tech, More

    Sep 25 | Clinical Research News | Moffitt Cancer Center announced a strategic collaboration with AstraZeneca that aims to accelerate the development of cell therapies, specifically chimeric antigen receptor T cell and T cell receptor therapies; Firefly Neuroscience announced the advancement of its artificial intelligence-powered Brain Network Analytics (BNA) technology; and more. More

  • PCORI Offers $100 Million For Youth Research, Children’s Health Promotion

    Sep 24 | Clinical Research News | PCORI announced earlier this month that they are inviting proposals through eight new funding opportunities. These include three PCORI Funding Announcements for patient-centered comparative clinical effectiveness research (CER). Letters of intent are due October 1, 2024, and applications will be accepted until January 14, 2025. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More